Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Suppliers / Biotechnology Equipment and Materials

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials

NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial

Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders

Sanofi’s Dupixent meets Phase III trial endpoints for rhinosinusitis

Cold Chain

Brexit backlash: EU cuts UK’s MHRA out of drug approval process

Roche’s Rituxan biosimilar woes are just beginning

Blockbuster asthma drug Xolair gains breakthrough status for food allergies

Diseases

Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth

Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders

Trial design should give Dermira’s AD drug a better shot at Phase IIb success

Drug Development

Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth

NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial

Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders

Manufacturing

NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial

How will the UK’s relaxed cannabis regulations impact clinical practice?

Roche reports sales growth as new drugs ease pressure from biosimilar competition

Market Data

Pace of cancer drug reimbursement varies wildly across Europe

Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka

Deals this week: Emergent BioSolutions, Pediapharm, Adynxx

Obsessions

NHS Genomic Medicine Service: the UK seeks to build a global genomic hub

Patient death following CAR-T therapy highlights serious manufacturing issues

Pharma Technology Focus – Special Issue